Clinical aspects of hepatitis B virus infection
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
1993 |
---|---|
Erschienen: |
1993 |
Enthalten in: |
Zur Gesamtaufnahme - volume:342 |
---|---|
Enthalten in: |
Lancet (London, England) - 342(1993), 8883 vom: 27. Nov., Seite 1340-4 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Wright, T L [VerfasserIn] |
---|
Anmerkungen: |
Date Completed 17.12.1993 Date Revised 11.03.2022 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM07670002X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM07670002X | ||
003 | DE-627 | ||
005 | 20231222032002.0 | ||
007 | tu | ||
008 | 231222s1993 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n0256.xml |
035 | |a (DE-627)NLM07670002X | ||
035 | |a (NLM)7694023 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Wright, T L |e verfasserin |4 aut | |
245 | 1 | 0 | |a Clinical aspects of hepatitis B virus infection |
264 | 1 | |c 1993 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 17.12.1993 | ||
500 | |a Date Revised 11.03.2022 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, U.S. Gov't, Non-P.H.S. | |
650 | 4 | |a Research Support, U.S. Gov't, P.H.S. | |
650 | 4 | |a Review | |
650 | 4 | |a Adult | |
650 | 4 | |a Age Factors | |
650 | 4 | |a Biology | |
650 | 4 | |a Blood Supply | |
650 | 4 | |a Chronic Diseases | |
650 | 4 | |a Delivery Of Health Care | |
650 | 4 | |a Demographic Factors | |
650 | 4 | |a Diseases | |
650 | 4 | |a Drugs | |
650 | 4 | |a Equipment And Supplies | |
650 | 4 | |a Health | |
650 | 4 | |a Health Services | |
650 | 4 | |a Hepatic Effects | |
650 | 4 | |a Hepatitis--transmission | |
650 | 4 | |a Histology | |
650 | 4 | |a Hiv Infections | |
650 | 4 | |a Immunization | |
650 | 4 | |a Infections | |
650 | 4 | |a Liver Cirrhosis | |
650 | 4 | |a Liver Neoplasms | |
650 | 4 | |a Neoplasms | |
650 | 4 | |a Obstacles | |
650 | 4 | |a Organization And Administration | |
650 | 4 | |a Physiology | |
650 | 4 | |a Population | |
650 | 4 | |a Population Characteristics | |
650 | 4 | |a Primary Health Care | |
650 | 4 | |a Reproductive Tract Infections | |
650 | 4 | |a Sexually Transmitted Diseases | |
650 | 4 | |a Signs And Symptoms | |
650 | 4 | |a Treatment | |
650 | 4 | |a Vaccination | |
650 | 4 | |a Viral Diseases | |
650 | 7 | |a Interferons |2 NLM | |
650 | 7 | |a 9008-11-1 |2 NLM | |
700 | 1 | |a Lau, J Y |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Lancet (London, England) |d 1945 |g 342(1993), 8883 vom: 27. Nov., Seite 1340-4 |w (DE-627)NLM000473936 |x 1474-547X |7 nnns |
773 | 1 | 8 | |g volume:342 |g year:1993 |g number:8883 |g day:27 |g month:11 |g pages:1340-4 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 342 |j 1993 |e 8883 |b 27 |c 11 |h 1340-4 |